| |
Your search for [subject]TIME FACTORS returned 7 records. |
|
| |
Sort by:
|
|
| |
|
|
| |
|
 |
Heterogeneity in long-term survivors a frailty model with immunes.
by Reyes, Christian Russel D; Quezon City: University of the Philippines, 2006.
Subject: Survival analysis; Time factors.
|
|
| |
|
|
|
|
| |
|
|
| |
|
 |
Dynamic sorption of ammonium by sandy soil in fixed bed columns: Evaluation of equilibrium and non-equilibrium transport processes.
by Jellali, S.; Amsterdam: Elsevier Ltd, 2009.
Subject: Hydrology; Dynamic sorption; Breakthrough curves; Adsorption; Time Factors.
|
|
| |
|
|
|
|
| |
|
|
| |
|
|
A comparative clinical trial in multibacillary leprosy with long-term relapse rates of four different multidrug regimens.
by Fajardo, Tranquilino T.;
Subject: DRUG ADMINISTRATION SCHEDULE; LEPROSTATIC AGENTS; LEPROSY; RECURRENCE; TIME FACTORS; YOUNG ADULT.
|
|
| |
|
|
|
|
| |
|
|
| |
|
|
Analysis of antibody responses to Mycobacterium leprae phenolic glycolipid I, lipoarabinomannan, and recombinant proteins to define disease subtype-specific antigenic profiles in leprosy.
by Gelber, Robert;
Subject: ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOLIPIDS; LEPROSY; LIPOPOLYSACCHARIDES; MYCOBACTERIUM LEPRAE; RECOMBINANT PROTEINS; TIME FACTORS.
|
|
| |
|
|
|
|
| |
|
|
| |
|
|
Survival analysis with long-term survivors.
by Maller, Ross A.; Chichester: Wiley, 1996.
Subject: Survival analysis (Biometry); Immunity; Survival Analysis; Survivors; Time Factors.
|
|
| |
|
|
|
|
| |
|
|
| |
|
|
Long-term relapse risk of multibacillary leprosy after completion of 2 years of multiple drug therapy (WHO-MDT) in Cebu, Philippines.
by Walsh, Douglas S.;
Subject: DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; LEPROSTATIC AGENTS; LEPROSY; MYCOBACTERIUM LEPRAE; RECURRENCE; TIME FACTORS; MULTIPLE DRUG THERAPY.
|
|
| |
|
|
|
|
| |
|
|
| |
|
|
The efficacy of a four-week, ofloxacin-containing regimen compared with standard who-mdt in PB leprosy.
by Balagon , MF;
Subject: DAPSONE; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; LEPROSTATIC AGENTS; LEPROSY, PAUCIBACILLARY; OFLOXACIN; RECURRENCE; RIFAMPIN; SKIN; TIME FACTORS; TREATMENT OUTCOME; COMBINATION DRUG THERAPY.
|
|
| |
|
|
|
|
| |
|
|
| |
